<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31398826</article-id>
<article-id pub-id-type="pmc">6720891</article-id>
<article-id pub-id-type="doi">10.3390/ijms20163862</article-id>
<article-id pub-id-type="publisher-id">ijms-20-03862</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling Neurological Disorders with Human Pluripotent Stem Cell-Derived Astrocytes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Suga</surname>
<given-names>Mika</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-03862">1</xref>
<xref ref-type="aff" rid="af2-ijms-20-03862">2</xref>
<xref ref-type="author-notes" rid="fn1-ijms-20-03862">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kondo</surname>
<given-names>Takayuki</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-03862">1</xref>
<xref ref-type="aff" rid="af2-ijms-20-03862">2</xref>
<xref ref-type="aff" rid="af3-ijms-20-03862">3</xref>
<xref ref-type="author-notes" rid="fn1-ijms-20-03862">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Inoue</surname>
<given-names>Haruhisa</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-03862">1</xref>
<xref ref-type="aff" rid="af2-ijms-20-03862">2</xref>
<xref ref-type="aff" rid="af3-ijms-20-03862">3</xref>
<xref ref-type="corresp" rid="c1-ijms-20-03862">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-20-03862"><label>1</label>iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto 619-0237, Japan</aff>
<aff id="af2-ijms-20-03862"><label>2</label>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan</aff>
<aff id="af3-ijms-20-03862"><label>3</label>Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto 606-8507, Japan</aff>
<author-notes>
<corresp id="c1-ijms-20-03862"><label>*</label>Correspondence: <email>haruhisa@cira.kyoto-u.ac.jp</email>; Tel.: +81-75-366-7036</corresp>
<fn id="fn1-ijms-20-03862">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>16</issue>
<elocation-id>3862</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Astrocytes play vital roles in neurological disorders. The use of human induced pluripotent stem cell (iPSC)-derived astrocytes provides a chance to explore the contributions of astrocytes in human diseases. Here we review human iPSC-based models for neurological disorders associated with human astrocytes and discuss the points of each model.</p>
</abstract>
<kwd-group>
<kwd>astrocytes</kwd>
<kwd>disease modeling</kwd>
<kwd>iPSC</kwd>
<kwd>induced pluripotent stem cells</kwd>
<kwd>glia</kwd>
<kwd>human neurological disorders</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-20-03862" sec-type="intro">
<title>1. Introduction</title>
<p>Astrocytes are the most abundant glial cell type in the central nerve system (CNS) and have multiple roles on neuronal development and function. Astrocytes regulate synaptogenesis, modulate synaptic plasticity, provide metabolic support to neurons, secrete or absorb neurotransmitters from synapses, regulate extracellular ion concentrations, support the brain–blood barrier (BBB), and promote myelination in the white matter. Conversely, their dysfunction has been implicated in several neurological disorders such as neurodegenerative diseases, neurodevelopmental diseases, epilepsy and astroglioma [<xref ref-type="bibr" rid="B1-ijms-20-03862">1</xref>,<xref ref-type="bibr" rid="B2-ijms-20-03862">2</xref>,<xref ref-type="bibr" rid="B3-ijms-20-03862">3</xref>].</p>
</sec>
<sec id="sec2-ijms-20-03862">
<title>2. Diversity of Astrocyte Functions and Phenotypes</title>
<p>Astrocytes are extremely specialized and heterogeneous in terms of morphology and function throughout the CNS. According to classical taxonomy, astrocytes are divided into two major classes, protoplasmic astrocytes in the gray matter and fibrous astrocytes in the white matter [<xref ref-type="bibr" rid="B4-ijms-20-03862">4</xref>]. Protoplasmic astrocytes have highly branched and complex processes that contact blood vessels and neurons, whereas fibrous astrocytes have elongated, more simple processes that contact blood vessels, oligodendrocytes, and axons at the nodes of Ranvier [<xref ref-type="bibr" rid="B5-ijms-20-03862">5</xref>]. Astrocytes are coupled by gap junctions and form large networks [<xref ref-type="bibr" rid="B6-ijms-20-03862">6</xref>]. Astrocytes also make contact and form gap-junction coupling with oligodendrocytes in different brain regions, termed panglial networks [<xref ref-type="bibr" rid="B7-ijms-20-03862">7</xref>,<xref ref-type="bibr" rid="B8-ijms-20-03862">8</xref>]. Recent studies found that astrocyte morphology and function diversify with age and location in the brain [<xref ref-type="bibr" rid="B2-ijms-20-03862">2</xref>,<xref ref-type="bibr" rid="B9-ijms-20-03862">9</xref>,<xref ref-type="bibr" rid="B10-ijms-20-03862">10</xref>,<xref ref-type="bibr" rid="B11-ijms-20-03862">11</xref>,<xref ref-type="bibr" rid="B12-ijms-20-03862">12</xref>,<xref ref-type="bibr" rid="B13-ijms-20-03862">13</xref>,<xref ref-type="bibr" rid="B14-ijms-20-03862">14</xref>]. For example, mouse neocortical protoplasmic astrocytes within layer II–IV exhibit distinct morphologies, structural interactions with synapses, and molecular expressions [<xref ref-type="bibr" rid="B15-ijms-20-03862">15</xref>]. How astrocytes acquire these different phenotypes during brain development and maturation is largely unknown.</p>
<p>Astrocytes acquire different reactive phenotypes when they respond to different pathological stimuli, such as infection, ischemia, neurodegenerative disorders, and aging. Reactive astrocytes have modulated gene expression profiles that regulate both structural and biochemical changes [<xref ref-type="bibr" rid="B9-ijms-20-03862">9</xref>,<xref ref-type="bibr" rid="B11-ijms-20-03862">11</xref>,<xref ref-type="bibr" rid="B16-ijms-20-03862">16</xref>]. Two major different types of reactive astrocytes, A1 and A2, were shown to be induced by injury and disease in the adult CNS [<xref ref-type="bibr" rid="B17-ijms-20-03862">17</xref>]. A1 astrocytes, which are induced by injury, neuroinflammation, and neurodegenerative disease, produce proinflammatory molecules and secrete molecules that are toxic to neural cells. Several cytokines including IL-1α, tumor necrosis factor (TNF) and C1q released by activated microglia can promote the formation of reactive A1 astrocytes such that the A1 astrocytes no longer promote neuronal survival, outgrowth, or synapse formation, nor phagocytize synapses or debris [<xref ref-type="bibr" rid="B6-ijms-20-03862">6</xref>]. On the other hand, A2 astrocytes, which are induced by ischemia, secrete neuroprotective cytokines including thrombospondins (TSPs) to provide neurotrophic support and modulate inflammatory responses that promote neuronal survival and tissue repair [<xref ref-type="bibr" rid="B17-ijms-20-03862">17</xref>]. Non-reactive astrocytes become reactive astrocytes with a spectrum of potential molecular, cellular, and functional changes, including neurotoxic or neuroprotective properties, in response to a wide range of extracellular signals and stress. Reactive changes in astrocyte properties occur in a context-dependent manner, and under each circumstance that would induce a continuum heterogeneous population of reactive astrocytes [<xref ref-type="bibr" rid="B18-ijms-20-03862">18</xref>,<xref ref-type="bibr" rid="B19-ijms-20-03862">19</xref>]. It is hypothesized that reactive astrocytes play a role not only in aging and age-related diseases including neurodegenerative disease, but also in neurodevelopmental diseases [<xref ref-type="bibr" rid="B9-ijms-20-03862">9</xref>,<xref ref-type="bibr" rid="B16-ijms-20-03862">16</xref>]. A1 astrocytes have been identified in the post-mortem brain tissues of individuals with neurological diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). Astrocytes display different phenotypes depending on the pathogenesis [<xref ref-type="bibr" rid="B3-ijms-20-03862">3</xref>]. Moreover, astrocyte reactivity is induced by normal aging [<xref ref-type="bibr" rid="B9-ijms-20-03862">9</xref>]. It was shown that astrocytes in aged mouse brains express genes associated with reactivity, particularly in the hippocampus and striatum, which are areas linked to neurodegenerative diseases [<xref ref-type="bibr" rid="B13-ijms-20-03862">13</xref>,<xref ref-type="bibr" rid="B16-ijms-20-03862">16</xref>]. Thus, astrocyte phenotypic changes have been implicated in the pathogenesis of a wide range of neurological disorders.</p>
</sec>
<sec id="sec3-ijms-20-03862">
<title>3. Human PSC-Derived Astrocytes as In Vitro Models</title>
<p>Human and rodent astrocytes show significant differences [<xref ref-type="bibr" rid="B5-ijms-20-03862">5</xref>,<xref ref-type="bibr" rid="B11-ijms-20-03862">11</xref>,<xref ref-type="bibr" rid="B20-ijms-20-03862">20</xref>], with human cortical astrocytes being larger, more complex and diverse [<xref ref-type="bibr" rid="B20-ijms-20-03862">20</xref>]. For example, human cortical protoplasmic astrocytes are nearly 2.6-fold larger in diameter and extend 10-fold more glial fibrillary acidic protein (GFAP)-expressing primary processes than their rodent counterparts [<xref ref-type="bibr" rid="B20-ijms-20-03862">20</xref>]. Furthermore, human cortical protoplasmic astrocytes propagate Ca<sup>2+</sup> waves approximately 4-fold faster than rodent cortical protoplasmic astrocytes [<xref ref-type="bibr" rid="B20-ijms-20-03862">20</xref>]. The two types also show distinct gene expression profiles [<xref ref-type="bibr" rid="B11-ijms-20-03862">11</xref>]. These differences must be considered when studying animal models. However, there is limited access to astrocytes from patient brain samples. Human astrocytoma cell lines [<xref ref-type="bibr" rid="B21-ijms-20-03862">21</xref>] and primary human adult and fetal astrocytes [<xref ref-type="bibr" rid="B11-ijms-20-03862">11</xref>] are available as in vitro cellular models, but fail to fully recapitulate human diseases.</p>
<p>Human pluripotent stem cells (PSCs), which include human embryonic stem cells (ESCs) [<xref ref-type="bibr" rid="B22-ijms-20-03862">22</xref>] and human induced pluripotent stem cells (iPSCs) [<xref ref-type="bibr" rid="B23-ijms-20-03862">23</xref>], can be used to model neurological diseases. Several protocols exist for the directed differentiation of human PSCs toward astrocytes. Furthermore, human ESCs and iPSCs with gene modification mimicking the mutation of the inherited disease can be generated, as too can iPSCs from the patient without gene modification. Accordingly, several studies have used human PSCs to model astrocyte function or dysfunction in neurological diseases (<xref ref-type="table" rid="ijms-20-03862-t001">Table 1</xref>).</p>
</sec>
<sec id="sec4-ijms-20-03862" sec-type="methods">
<title>4. Methods for Generating Human PSC-Derived Astrocytes</title>
<p>Since the derivation of neural precursors from human ESCs was reported in 2001 [<xref ref-type="bibr" rid="B41-ijms-20-03862">41</xref>,<xref ref-type="bibr" rid="B42-ijms-20-03862">42</xref>], various differentiation protocols for neural cells including astrocytes from human PSCs have been described [<xref ref-type="bibr" rid="B24-ijms-20-03862">24</xref>,<xref ref-type="bibr" rid="B29-ijms-20-03862">29</xref>,<xref ref-type="bibr" rid="B43-ijms-20-03862">43</xref>,<xref ref-type="bibr" rid="B44-ijms-20-03862">44</xref>,<xref ref-type="bibr" rid="B45-ijms-20-03862">45</xref>,<xref ref-type="bibr" rid="B46-ijms-20-03862">46</xref>,<xref ref-type="bibr" rid="B47-ijms-20-03862">47</xref>,<xref ref-type="bibr" rid="B48-ijms-20-03862">48</xref>,<xref ref-type="bibr" rid="B49-ijms-20-03862">49</xref>,<xref ref-type="bibr" rid="B50-ijms-20-03862">50</xref>]. Most of them were developed by recapturing embryonic developmental events, although astrocyte development is not fully understood. Protocols for generating astrocytes from human PSCs generally consist of four main steps: (1) Conversion of the undifferentiated human PSCs into rosette-forming neuroepithelial cells; (2) Induction of the neural stem cells with or without morphogens for regional patterning; (3) Glia lineage specification by long-term expansion of the induced neural stem cells either in adhesion or suspension culture with growth factors; and (4) Astrocyte terminal differentiation and maturation [<xref ref-type="bibr" rid="B43-ijms-20-03862">43</xref>,<xref ref-type="bibr" rid="B51-ijms-20-03862">51</xref>].</p>
<p>To obtain neural stem cells, the serum-free culture of embryoid body (SFEB) method [<xref ref-type="bibr" rid="B47-ijms-20-03862">47</xref>] and the SFEB with quick aggregation (SFEBq) method [<xref ref-type="bibr" rid="B48-ijms-20-03862">48</xref>] have been used as well as the dual inhibition of SMAD signaling in adherent human PSC cultures [<xref ref-type="bibr" rid="B52-ijms-20-03862">52</xref>]. Alternatively, long-term self-renewing human iPSC-derived neuroepithelial stem cells (ltNES) [<xref ref-type="bibr" rid="B53-ijms-20-03862">53</xref>] can be used for astrocyte differentiation as well as neuronal differentiation [<xref ref-type="bibr" rid="B49-ijms-20-03862">49</xref>].</p>
<p>The combination of morphogens and growth factors, such as FGF8, RA, or SHH [<xref ref-type="bibr" rid="B54-ijms-20-03862">54</xref>,<xref ref-type="bibr" rid="B55-ijms-20-03862">55</xref>,<xref ref-type="bibr" rid="B56-ijms-20-03862">56</xref>], were used for rostral-caudal and dorsal-ventral patterning during the induction and regional specification of neural stem cells [<xref ref-type="bibr" rid="B57-ijms-20-03862">57</xref>]. The induced cells expressed distinct homeodomain transcription factors and displayed phenotypic differences [<xref ref-type="bibr" rid="B57-ijms-20-03862">57</xref>]. Using these techniques, researchers separately generated region-specific astrocyte subtypes including spinal cord astrocytes, midbrain astrocytes, and neocortical astrocytes [<xref ref-type="bibr" rid="B43-ijms-20-03862">43</xref>,<xref ref-type="bibr" rid="B57-ijms-20-03862">57</xref>,<xref ref-type="bibr" rid="B58-ijms-20-03862">58</xref>,<xref ref-type="bibr" rid="B59-ijms-20-03862">59</xref>].</p>
<p>Astrocyte lineage specification and terminal differentiation are conducted with growth factor-rich undefined medium such as fetal bovine serum-containing medium, growth factor-defined medium or growth factor-reduced medium. The efficiency of the terminal differentiation is independent of the growth factors used. On the other hand, serum accelerates terminal differentiation. Although astrocytes can be expanded easily in vitro, they tend to undergo senescence with the exhaustion of growth factors [<xref ref-type="bibr" rid="B60-ijms-20-03862">60</xref>,<xref ref-type="bibr" rid="B61-ijms-20-03862">61</xref>]. Serum components also may change the astrocyte phenotype. Indeed, acutely purified primary astrocytes exhibit extensive process-bearing morphologies under serum-free media, but exhibit polygonal fibroblast-like morphologies under serum-containing media [<xref ref-type="bibr" rid="B11-ijms-20-03862">11</xref>]. Furthermore, a serum-containing medium induces a phenotypic change and reactivity to human iPSC-derived astrocytes [<xref ref-type="bibr" rid="B35-ijms-20-03862">35</xref>]. Thus, in vitro culture conditions should be controlled very carefully. Two groups [<xref ref-type="bibr" rid="B43-ijms-20-03862">43</xref>,<xref ref-type="bibr" rid="B57-ijms-20-03862">57</xref>] have described methods to generate functional astrocytes from human PSCs under serum-free conditions. The maturation of astrocytes is also important to recapitulate the physiological function or disease phenotype. Long-term cultivation as a three-dimensional (3D) structure can accelerate the maturation of iPSC-derived astrocytes. Sloan et al. conducted up to 20 months cultivation of iPSC-derived astrocytes in 3D cortical neurospheres. Astrocytes after long-time culture closely resembled primary human fetal astrocytes and showed similar global gene-expression patterns and functions to that of primary human astrocytes [<xref ref-type="bibr" rid="B62-ijms-20-03862">62</xref>]. It is likely that the astrocyte function requires integration of the cells into a system. Yet, it is unknown if astrocytes in the entire brain form just a single (syncytium) or multiple networks (syncytia) through gap junctional coupling [<xref ref-type="bibr" rid="B63-ijms-20-03862">63</xref>]. iPSC-derived astrocytes partially recapitulate functional networks by simply assessing calcium influx spread [<xref ref-type="bibr" rid="B43-ijms-20-03862">43</xref>,<xref ref-type="bibr" rid="B49-ijms-20-03862">49</xref>]. However, these systems lack a robust astrocytic network which can modulate neuronal activity, signal transmission, or vessel contraction. Additionally, it is the future target to define the “healthy or normal” character in Ca<sup>2+</sup> oscillation or spread for disease modeling, because of the wide-variety of Ca<sup>2+</sup> spreading mechanisms [<xref ref-type="bibr" rid="B64-ijms-20-03862">64</xref>]. Therefore, it is the incoming step to construct a culture system, consisting of multiple cell types to mimic human brain and model disorders in the future.</p>
<p>Alternatively, the direct conversion of skin fibroblasts to astrocytes was reported [<xref ref-type="bibr" rid="B44-ijms-20-03862">44</xref>]. The defined transcription factors nuclear factor I A (NFIA), nuclear factor I B (NFIB), and SRY-box transcription factor 9 (SOX9) induce an astrocytic phenotype in human fibroblasts [<xref ref-type="bibr" rid="B44-ijms-20-03862">44</xref>]. In addition, a recent study demonstrated that human PSCs acquire glial fate by the transient forced activation of NFIA and SOX9 tandemly or NFIA alone, and further differentiated into functional astrocytes [<xref ref-type="bibr" rid="B46-ijms-20-03862">46</xref>,<xref ref-type="bibr" rid="B65-ijms-20-03862">65</xref>]. Understanding the molecular mechanisms in astrocyte specification will lead to improved molecular activation to enable PSC-derived astrocytes with better operability and better yield in the future.</p>
</sec>
<sec id="sec5-ijms-20-03862">
<title>5. Modeling Neurological Disorders Using Human PSC-Derived Astrocytes</title>
<p>Below we highlighted the modeling of several neurological disorders with human PSC-derived astrocytes.</p>
<sec id="sec5dot1-ijms-20-03862">
<title>5.1. Alzheimer’s Disease</title>
<p>Alzheimer’s disease (AD) is the most common dementia worldwide. In AD, astrocyte pathology is expressed even before neuronal death. Astrocytes in rodent AD models and AD patients become reactive, have aberrant calcium signaling, and change their gene expression profile and metabolism [<xref ref-type="bibr" rid="B3-ijms-20-03862">3</xref>]. AD astrocytes display elevated levels of GFAP expression and GABA production and release [<xref ref-type="bibr" rid="B66-ijms-20-03862">66</xref>]. Moreover, amyloid-β(Aβ) accumulates in AD astrocytes. Most cases of AD are late-onset sporadic AD, 1–2% are early-onset familial AD with underlying gene mutations in amyloid precursor protein (APP) or presenilin-1 and -2 (PSEN1/2) [<xref ref-type="bibr" rid="B67-ijms-20-03862">67</xref>].</p>
<p>We generated iPSCs from one sporadic AD patient and two familial AD patients with APP E693Δ mutation and APP V717L mutation. The AD iPSCs were differentiated into neurons and astrocytes, in which Aβ oligomers were found to have accumulated [<xref ref-type="bibr" rid="B24-ijms-20-03862">24</xref>]. We further used the AD iPSC model for drug screening and discovered that docosahexaenoic acid (DHA) may be effective for a subset of AD patients to reduce or prevent the symptoms [<xref ref-type="bibr" rid="B24-ijms-20-03862">24</xref>].</p>
<p>Oksanen et al. generated iPSCs from three AD patients with PSEN1 exon 9 deletion and analyzed the AD iPSC-derived astrocytes [<xref ref-type="bibr" rid="B25-ijms-20-03862">25</xref>]. The AD astrocytes exhibited increased Aβ production, altered cytokine release, and dysregulated Ca<sup>2+</sup> homeostasis [<xref ref-type="bibr" rid="B25-ijms-20-03862">25</xref>]. Furthermore, due to the altered metabolism, the AD astrocytes showed increased oxidative stress and reduced lactate secretion, as well as compromised neuronal supportive function, as evidenced by altering Ca<sup>2+</sup> transients in the healthy neurons.</p>
</sec>
<sec id="sec5dot2-ijms-20-03862">
<title>5.2. Parkinson’s Disease</title>
<p>Parkinson’s disease (PD) is the second most common neurodegenerative disease and is characterized by a significant loss of ventral midbrain dopaminergic neurons in the substantia nigra pars compacta. A pathological hallmark of PD is the accumulation of Lewy bodies (LBs), which mainly consist of α-synuclein, and α-synuclein aggregates spread from neuron to neuron in PD lesions [<xref ref-type="bibr" rid="B68-ijms-20-03862">68</xref>]. Most PD cases are sporadic, but monogenic mutations in 17 genes have been identified and implicated in the PD pathogenesis [<xref ref-type="bibr" rid="B69-ijms-20-03862">69</xref>]. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common cause of inherited PD, particularly the G2019S mutation in LRRK2 [<xref ref-type="bibr" rid="B69-ijms-20-03862">69</xref>].</p>
<p>Di Domenico et al. generated iPSC-derived astrocytes and dopaminergic neurons from familial PD patients carrying the G2019S mutation and compared the cells with iPSC-derived astrocytes and dopaminergic neurons from healthy controls [<xref ref-type="bibr" rid="B26-ijms-20-03862">26</xref>]. They demonstrated that α-synuclein, secreted from the PD iPSC-derived astrocytes, exerted neurotoxic function on surrounding dopaminergic neurons, leading to a non-cell-autonomous neuronal dysfunction. In addition, they identified dysfunctional chaperone-mediated autophagy (CMA), impaired macroautophagy, and progressive α-synuclein accumulation in the PD iPSC-derived astrocytes. Furthermore, the reactivation of CMA protected the PD iPSC-derived astrocytes and dopaminergic neurons via the clearance of α-synuclein accumulation [<xref ref-type="bibr" rid="B26-ijms-20-03862">26</xref>]. These findings described a non-cell-autonomous contribution of astrocytes during PD pathogenesis.</p>
</sec>
<sec id="sec5dot3-ijms-20-03862">
<title>5.3. Huntington’s Disease</title>
<p>Huntington’s disease (HD) is a progressive and fatal neurodegenerative disorder caused by the trinucleotide repeat expansion (CAG) in exon 1 of the huntingtin (HTT) gene. The CAG repeat expansion causes an expanded polyglutamine tract at the amino terminus of the HTT protein. The mutant HTT protein accumulates and aggregates not only in neurons, including medium spiny neurons of the striatum, but also in other neural cell types such as astrocytes in the brain of HD patients [<xref ref-type="bibr" rid="B70-ijms-20-03862">70</xref>].</p>
<p>Juopperi et al. generated iPSCs from a father with adult-onset HD and 50 CAG repeats and his daughter with juvenile HD and 109 CAG repeats [<xref ref-type="bibr" rid="B27-ijms-20-03862">27</xref>]. The astrocytes derived from the HD-specific iPSCs exhibited a large number of cytoplasmic, electron clear vacuoles a phenomenon seen in HD patients. The severity of this phenotype was dependent on the number of CAG repeats.</p>
</sec>
<sec id="sec5dot4-ijms-20-03862">
<title>5.4. Tauopathy</title>
<p>Mutations in the gene encoding the microtubule-associated protein TAU (MAPT) are a common cause of frontotemporal dementia (FTD), a group of neurodegenerative diseases characterized by progressive nerve cell loss in the frontal lobes and the temporal lobes in the brain.</p>
<p>Hallmann et al. generated iPSCs from one FTD patient carrying the N279K MAPT mutation to establish a cell model of the astrocyte pathology in FTD. In their study, FTD iPSC-derived neurons and astrocytes were analyzed. The FTD astrocytes showed disease-associated changes in the TAU expression, increased vulnerability to oxidative stress and increased protein ubiquitination. Co-culture of healthy control neurons with FTD iPSC-derived astrocytes demonstrated that the astrocytes induced alterations in stress-response and gene-expression profiles in the neurons [<xref ref-type="bibr" rid="B28-ijms-20-03862">28</xref>].</p>
</sec>
<sec id="sec5dot5-ijms-20-03862">
<title>5.5. TDP-43 Proteinopathy</title>
<p>Transactive response DNA-binding protein (TDP-43) forms ubiquitinated inclusions in the cytoplasm and nuclei of neurons and astrocytes in patients with amyotrophic lateral sclerosis (ALS) or frontotemporal lobar dementia (FTLD). Consistently, mutations in the TDP-43 gene are a common cause of familial ALS and FTLD.</p>
<p>Serio et al. generated functional astrocytes from human iPSCs carrying a TDP-43 mutation and showed that the mutant TDP43 astrocytes exhibited increased levels of TDP-43, impaired subcellular localization of TDP-43, and decreased cell survival [<xref ref-type="bibr" rid="B29-ijms-20-03862">29</xref>]. However, the mutant TDP-43 astrocytes did not adversely affect the survival of cocultured neurons, suggesting a glial cell-autonomous pathological phenotype is associated with the TDP-43 proteinopathy.</p>
</sec>
<sec id="sec5dot6-ijms-20-03862">
<title>5.6. Amyotrophic Lateral Sclerosis</title>
<p>ALS is a group of rare neurological diseases characterized by the progressive degeneration of motor neurons, resulting in progressive muscle weakness and respiratory failure. More than 90% of ALS cases are considered sporadic, with the remaining considered familial. Among familial ALS, 20% are linked to various point mutations in the Cu/Zn superoxide dismutase 1 (SOD1) gene.</p>
<p>Wada et al. generated human ESCs overexpressing SOD1 mutant (G93A) by gene editing and then differentiated them to spinal motor neurons and astrocytes [<xref ref-type="bibr" rid="B30-ijms-20-03862">30</xref>]. The astrocytes were found to secrete factors toxic to the spinal motor neurons [<xref ref-type="bibr" rid="B30-ijms-20-03862">30</xref>]. Tyzack et al. showed that ephrin type-B receptor 1 (EphB1) is upregulated in injured motor neurons and that EphB1 induces astrocytic STAT3 signaling followed by a protective and anti-inflammatory signature in astrocytes [<xref ref-type="bibr" rid="B31-ijms-20-03862">31</xref>]. They generated astrocytes from ALS patient-iPSCs carrying SOD1 mutation (D90A) and demonstrated that EphB1 and the downstream pathway is disrupted [<xref ref-type="bibr" rid="B31-ijms-20-03862">31</xref>]. These ALS studies identified the increase of astrocytic toxicity and dysfunction of the neuroprotective astrocytic response.</p>
</sec>
<sec id="sec5dot7-ijms-20-03862">
<title>5.7. Spinal Muscular Atrophy</title>
<p>Spinal muscular atrophy (SMA) is a group of childhood neurodegenerative disorders caused by loss or mutations in the survival motor neuron 1 (SMN1). SMA is characterized by a loss of motor neurons or anterior horn cells, resulting in progressive muscle weakness and muscle wasting in proximal muscles, respiratory difficulty, paralysis, and death.</p>
<p>McGivern et al. established iPSC-derived astrocytes from patients with SMA, and reported that the astrocytes had larger cell bodies and shorter processes, reduced GDNF expression, increased basal calcium levels and decreased response to ATP stimulation [<xref ref-type="bibr" rid="B32-ijms-20-03862">32</xref>]. The SMA iPSC-derived astrocyte models suggested that reactive astrocytes are involved in motor neuron loss in SMA.</p>
</sec>
<sec id="sec5dot8-ijms-20-03862">
<title>5.8. Alexander Disease</title>
<p>Alexander disease (AxD) is a rare inherited neurodegenerative disorder that primarily affects astrocytes. A variety of <italic>GFAP</italic> gene mutations causes astrocyte dysfunction in AxD [<xref ref-type="bibr" rid="B71-ijms-20-03862">71</xref>,<xref ref-type="bibr" rid="B72-ijms-20-03862">72</xref>]. The common neuropathological features of AxD are the degeneration of white matter (leukodystrophy) and the formation of cytoplasmic inclusions, termed Rosenthal fibers, within the astrocytes [<xref ref-type="bibr" rid="B71-ijms-20-03862">71</xref>,<xref ref-type="bibr" rid="B72-ijms-20-03862">72</xref>,<xref ref-type="bibr" rid="B73-ijms-20-03862">73</xref>].</p>
<p>We generated iPSCs from three AxD patients and differentiated them into astrocytes, in which Rosenthal fiber-like structures and GFAP-positive aggregates were observed [<xref ref-type="bibr" rid="B33-ijms-20-03862">33</xref>]. The AxD astrocytes produced and released more inflammatory cytokines than healthy control iPSC-derived astrocytes, suggesting that the AxD astrocyte models recapitulate the leukodystrophy and a variety of other AxD features [<xref ref-type="bibr" rid="B33-ijms-20-03862">33</xref>]. Li et al. also established AxD astrocyte models from three AxD patient-iPSCs [<xref ref-type="bibr" rid="B34-ijms-20-03862">34</xref>]. These iPS-derived astrocytes exhibited Rosenthal fiber-like structures and GFAP aggregation. Using a co-culture system of AxD iPS-derived astrocytes and oligodendrocytes, Li et al. found that the astrocytes secreted more molecules that inhibited oligodendrocyte progenitor cell function and impair myelination [<xref ref-type="bibr" rid="B34-ijms-20-03862">34</xref>].</p>
</sec>
<sec id="sec5dot9-ijms-20-03862">
<title>5.9. Multiple Sclerosis</title>
<p>Multiple sclerosis (MS) is an auto-inflammatory disease of the CNS. It is characterized by demyelination followed by axonal loss and neurodegeneration [<xref ref-type="bibr" rid="B74-ijms-20-03862">74</xref>]. In MS, reactive astrocytes are present around the lesions [<xref ref-type="bibr" rid="B74-ijms-20-03862">74</xref>,<xref ref-type="bibr" rid="B75-ijms-20-03862">75</xref>], however, the pathogenesis and cause of MS is largely unknown.</p>
<p>Perriot et al. generated iPSCs from four MS patients [<xref ref-type="bibr" rid="B35-ijms-20-03862">35</xref>]. They found IL-1b, TNF-a, and IL-6, all cytokines important for the neuroinflammation seen in MS, in a serum-free culture system triggered a specific reactivity in the iPSC-derived astrocytes.</p>
</sec>
<sec id="sec5dot10-ijms-20-03862">
<title>5.10. Autism Spectrum Disorder</title>
<p>Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders. A small percentage of ASD is syndromic ASD with copy number variants (CNVs) or mutations in ASD-risk genes, but most are non-syndromic ASD with unknown genetic etiology [<xref ref-type="bibr" rid="B76-ijms-20-03862">76</xref>].</p>
<p>Russo et al. generated iPSCs from a clinically well-characterized cohort of three individuals with non-syndromic ASD sharing common behaviors [<xref ref-type="bibr" rid="B36-ijms-20-03862">36</xref>]. Analyzing the synaptogenesis and neuronal activity of a mixed neuron culture derived from ASD iPSCs, they found that the neurons had a significant decrease in synaptic gene expression and protein levels, glutamate neurotransmitter release, and, consequently, reduced spontaneous firing rate. Moreover, co-culture experiments of the ASD iPSC-derived astrocytes and neurons revealed that cytokines including interleukin-6 (IL-6) secreted from the astrocytes, interfered with proper neuronal development.</p>
</sec>
<sec id="sec5dot11-ijms-20-03862">
<title>5.11. Rett Syndrome</title>
<p>Rett syndrome (RTT) is a rare neurodevelopmental disorder caused by a variety of mutations in the Methyl-CpG-binding protein2 (<italic>MECP2</italic>) gene on the X chromosome. RTT patients show abnormalities in cognitive, sensory, emotional, motor and autonomic functions, but the disease mechanism is not well understood. Mouse models have shown that MeCP2 deficiency in astrocytes causes abnormal BDNF regulation, cytokine production, and neuronal dendritic induction [<xref ref-type="bibr" rid="B1-ijms-20-03862">1</xref>,<xref ref-type="bibr" rid="B77-ijms-20-03862">77</xref>].</p>
<p>Williams et al. generated iPSC lines from RTT patients carrying the V247X (valine 247 to stop codon, nonsense), R294X (arginine 294 to stop codon, nonsense) or R306C (arginine 306 to cysteine, missense) mutations [<xref ref-type="bibr" rid="B78-ijms-20-03862">78</xref>] and differentiated them into astrocytes [<xref ref-type="bibr" rid="B37-ijms-20-03862">37</xref>].</p>
<p>Neurons co-cultured with astrocytes derived from RTT iPSCs showed shorter neurite length and fewer terminal ends than if co-cultured with control astrocytes [<xref ref-type="bibr" rid="B37-ijms-20-03862">37</xref>]. These phenotypes are consistent with RTT pathologies. Moreover, the study demonstrated that both insulin-like growth factor 1 (IGF1) and GPE (a peptide containing the first three amino acids of IGF-1) partially rescued the neuronal deficits caused by the RTT astrocytes. Andoh-Noda et al. generated two iPSC lines from RTT twins with a de novo frame-shift mutation in MECP2 (G269AfsX288) [<xref ref-type="bibr" rid="B38-ijms-20-03862">38</xref>,<xref ref-type="bibr" rid="B79-ijms-20-03862">79</xref>]. They demonstrated that the RTT iPSC lines did not express detectable MeCP2 protein during any stage of differentiation into neural cells and that MeCP2 deficiency triggers a change in the astrocytic gene expression, yielding accelerated astrocyte formation from RTT iPSC-derived neural stem cells [<xref ref-type="bibr" rid="B38-ijms-20-03862">38</xref>]. Finally, Delépine et al. identified altered microtubule dynamics and impaired vesicular transport in RTT iPSC-derived astrocytes carrying the MECP2 gene mutation (R294X) [<xref ref-type="bibr" rid="B39-ijms-20-03862">39</xref>]. These studies have shed light on astrocytic abnormalities in RTT and suggested that astrocytes might be a target of RTT therapy.</p>
</sec>
<sec id="sec5dot12-ijms-20-03862">
<title>5.12. Epilepsy</title>
<p>Epilepsy is one of the common neurological disorder in which hypersynchronous neuronal firing occurs as a consequence of intensive burst activity from groups of neurons. Epilepsy can be genetic or acquired, although the cause is unknown in most cases. Childhood epileptic encephalopathies (CEEs) such as Dravet syndrome, Angelman syndrome, and Rett syndrome (RTT) are increasingly linked to specific genetic mutations. iPSC-derived neural cells, including GABAergic or glutamatergic neurons, have come to be a common tool to model epileptic disorders [<xref ref-type="bibr" rid="B80-ijms-20-03862">80</xref>]. Astrocyte regulates neurotransmission by encasing thousands of synapses to form tripartite synapses between pre- and postsynaptic structures of two neurons and the surrounding astrocytic process [<xref ref-type="bibr" rid="B81-ijms-20-03862">81</xref>]. Astrocytes also contact blood vessels and other glial cells, affecting neurotransmission. Therefore, astrocytes have a key role in the seizure activity, in addition to the well-established neurogenic mechanisms [<xref ref-type="bibr" rid="B3-ijms-20-03862">3</xref>,<xref ref-type="bibr" rid="B82-ijms-20-03862">82</xref>].</p>
<p>A total of 70–80% of patients with RTT develop seizures. As mentioned in earlier sections, astrocytes derived from iPSC of RTT patients do not have enough ability to support neurite outgrowth or synapse formation [<xref ref-type="bibr" rid="B37-ijms-20-03862">37</xref>]. In the case of drug-induced epilepsy, single-cell transcriptome analysis of cocultured iPSC-derived neurons and astrocytes clarified that the iPSC-derived astrocyte upregulate the activities of AMPA and NMDA receptors, which is directly related to epileptiform discharge by gabazine or kaliotoxin [<xref ref-type="bibr" rid="B40-ijms-20-03862">40</xref>].</p>
</sec>
</sec>
<sec id="sec6-ijms-20-03862">
<title>6. Closing Remarks</title>
<p>Astrocytes play a key role in many neurological disorders, but details are still lacking. Astrocytes derived from human PSCs with disease-specific gene mutations can be a powerful tool to understanding the cellular phenotypes and disease mechanisms in vitro. These models are expected to clarify how astrocytes contribute to neurological disorders including the underlying mechanisms.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We would like to express our sincere gratitude to all our coworkers and collaborators: Ran Shibukawa, Yukako Sagara, Yasue Okanishi, Kazuma Kamata, Aya Washida, Kayoko Tsukita, Takako Enami, Ayako Nagahashi for technical assistance; Peter Karagiannis for critical reading and editing of the manuscript; and Makiko Yasui, Mikie Iijima, Nozomi Kawabata, Ayumi Suzuki, Kiyomi Hatae, and Miwa Fujita for their valuable administrative support.</p>
</ack>
<notes>
<title>Funding</title>
<p>This research was funded in part by a grant for Core Center for iPS Cell Research of Research Center Network for Realization of Regenerative Medicine from AMED to H.I. and from KAKENHI (18K18452, 18H02717) to T.K, and H.I., KAKENHI (17K16121) to T.K, and KAKENHI (19K07986) to M.S.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-20-03862">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molofsky</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Krenick</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ullian</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>H.-H.</given-names>
</name>
<name>
<surname>Deneen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>W.D.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Rowitch</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Astrocytes and disease: A neurodevelopmental perspective</article-title>
<source/>Genes Dev.
          <year>2012</year>
<volume>26</volume>
<fpage>891</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="doi">10.1101/gad.188326.112</pub-id>
<pub-id pub-id-type="pmid">22549954</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-20-03862">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>C.-C.J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hatcher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.-W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weston</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of diverse astrocyte populations and their malignant analogs</article-title>
<source/>Nat. Neurosci.
          <year>2017</year>
<volume>20</volume>
<fpage>396</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">28166219</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-20-03862">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dossi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vasile</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rouach</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Human astrocytes in the diseased brain</article-title>
<source/>Brain Res. Bull.
          <year>2018</year>
<volume>136</volume>
<fpage>139</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresbull.2017.02.001</pub-id>
<pub-id pub-id-type="pmid">28212850</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-20-03862">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Raff</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct</article-title>
<source/>J. Neurosci.
          <year>1984</year>
<volume>4</volume>
<fpage>585</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.04-02-00585.1984</pub-id>
<pub-id pub-id-type="pmid">6366155</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-20-03862">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundgaard</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Osorio</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Kress</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Sanggaard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>White matter astrocytes in health and disease</article-title>
<source/>Neuroscience
          <year>2014</year>
<volume>276</volume>
<fpage>161</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.10.050</pub-id>
<pub-id pub-id-type="pmid">24231735</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-20-03862">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutnick</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Connors</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ransom</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Dye-coupling between glial cells in the guinea pig neocortical slice</article-title>
<source/>Brain Res.
          <year>1981</year>
<volume>213</volume>
<fpage>486</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(81)90259-6</pub-id>
<pub-id pub-id-type="pmid">7248773</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-20-03862">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griemsmann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hoft</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Bedner</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>von Staden</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Beinhauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Degen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dublin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cope</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of panglial gap junction networks in the thalamus, neocortex, and hippocampus reveals a unique population of glial cells</article-title>
<source/>Cereb. Cortex
          <year>2015</year>
<volume>25</volume>
<fpage>3420</fpage>
<lpage>3433</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhu157</pub-id>
<pub-id pub-id-type="pmid">25037920</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-20-03862">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beiersdorfer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scheller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kirchhoff</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lohr</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Panglial gap junctions between astrocytes and olfactory ensheathing cells mediate transmission of ca<sup>2+</sup> transients and neurovascular coupling</article-title>
<source/>Glia
          <year>2019</year>
<volume>67</volume>
<fpage>1385</fpage>
<lpage>1400</lpage>
<pub-id pub-id-type="doi">10.1002/glia.23613</pub-id>
<pub-id pub-id-type="pmid">30883940</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-20-03862">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liddelow</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Guttenplan</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Bohlen</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Schirmer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Münch</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>W.-S.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>T.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurotoxic reactive astrocytes are induced by activated microglia</article-title>
<source/>Nature
          <year>2017</year>
<volume>541</volume>
<fpage>481</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1038/nature21029</pub-id>
<pub-id pub-id-type="pmid">28099414</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-20-03862">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Scholze</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>O’Keeffe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Phatnani</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Guarnieri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Caneda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ruderisch</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<fpage>11929</fpage>
<lpage>11947</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1860-14.2014</pub-id>
<pub-id pub-id-type="pmid">25186741</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-20-03862">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Caneda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Plaza</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse</article-title>
<source/>Neuron
          <year>2016</year>
<volume>89</volume>
<fpage>37</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.11.013</pub-id>
<pub-id pub-id-type="pmid">26687838</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-20-03862">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>V.T.</given-names>
</name>
<name>
<surname>Fuh</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Sawaya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>M.-K.</given-names>
</name>
<name>
<surname>Bedell</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Antel</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Ludwin</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Sarnat</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Bar-Or</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>MicroRNA Expression Patterns in Human Astrocytes in Relation to Anatomical Location and Age</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>2016</year>
<volume>75</volume>
<fpage>156</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1093/jnen/nlv016</pub-id>
<pub-id pub-id-type="pmid">26802178</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-20-03862">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boisvert</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Erikson</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Shokhirev</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>N.J.</given-names>
</name>
</person-group>
<article-title>The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain</article-title>
<source/>Cell Rep.
          <year>2018</year>
<volume>22</volume>
<fpage>269</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.039</pub-id>
<pub-id pub-id-type="pmid">29298427</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-20-03862">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Emsley</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Macklis</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS</article-title>
<source/>Neuron Glia Boil.
          <year>2006</year>
<volume>2</volume>
<fpage>175</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1017/S1740925X06000202</pub-id>
<pub-id pub-id-type="pmid">17356684</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-20-03862">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanjakornsiripan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pior</surname>
<given-names>B.-J.</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Furutachi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tahara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Katsuyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fukazawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gotoh</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Layer-specific morphological and molecular differences in neocortical astrocytes and their dependence on neuronal layers</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<fpage>1623</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-03940-3</pub-id>
<pub-id pub-id-type="pmid">29691400</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-20-03862">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Liddelow</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Münch</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Heiman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Normal aging induces a1-like astrocyte reactivity</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>E1896</fpage>
<lpage>E1905</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1800165115</pub-id>
<pub-id pub-id-type="pmid">29437957</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-20-03862">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamanian</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Foo</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Giffard</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Genomic Analysis of Reactive Astrogliosis</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>6391</fpage>
<lpage>6410</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6221-11.2012</pub-id>
<pub-id pub-id-type="pmid">22553043</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-20-03862">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofroniew</surname>
<given-names>M.V.</given-names>
</name>
</person-group>
<article-title>Astrogliosis</article-title>
<source/>Cold Spring Harb. Perspect. Biol.
          <year>2014</year>
<volume>7</volume>
<fpage>a020420</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a020420</pub-id>
<pub-id pub-id-type="pmid">25380660</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-20-03862">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liddelow</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Reactive Astrocytes: Production, Function, and Therapeutic Potential</article-title>
<source/>Immunity
          <year>2017</year>
<volume>46</volume>
<fpage>957</fpage>
<lpage>967</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2017.06.006</pub-id>
<pub-id pub-id-type="pmid">28636962</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-20-03862">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oberheim</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.H.C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wyatt</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Pilcher</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ojemann</surname>
<given-names>J.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Uniquely hominid features of adult human astrocytes</article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<fpage>3276</fpage>
<lpage>3287</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4707-08.2009</pub-id>
<pub-id pub-id-type="pmid">19279265</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-20-03862">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Efthymiou</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Heman-Ackah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Comparison of the Gene Expression Profiles of Human Fetal Cortical Astrocytes with Pluripotent Stem Cell Derived Neural Stem Cells Identifies Human Astrocyte Markers and Signaling Pathways and Transcription Factors Active in Human Astrocytes</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e96139</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0096139</pub-id>
<pub-id pub-id-type="pmid">24848099</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-20-03862">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomson</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Embryonic Stem Cell Lines Derived from Human Blastocysts</article-title>
<source/>Science
          <year>1998</year>
<volume>282</volume>
<fpage>1145</fpage>
<lpage>1147</lpage>
<pub-id pub-id-type="doi">10.1126/science.282.5391.1145</pub-id>
<pub-id pub-id-type="pmid">9804556</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-20-03862">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ohnuki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Narita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ichisaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tomoda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors</article-title>
<source/>Cell
          <year>2007</year>
<volume>131</volume>
<fpage>861</fpage>
<lpage>872</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.11.019</pub-id>
<pub-id pub-id-type="pmid">18035408</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-20-03862">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Asai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsukita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kutoku</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohsawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sunada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Imamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Egawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yahata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Okita</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modeling alzheimer’s disease with ipscs reveals stress phenotypes associated with intracellular abeta and differential drug responsiveness</article-title>
<source/>Cell Stem Cell
          <year>2013</year>
<volume>12</volume>
<fpage>487</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2013.01.009</pub-id>
<pub-id pub-id-type="pmid">23434393</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-20-03862">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oksanen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Naumenko</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Puttonen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lehtonen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gubert Olive</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shakirzyanova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Leskela</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sarajarvi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Viitanen</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Psen1 mutant ipsc-derived model reveals severe astrocyte pathology in alzheimer’s disease</article-title>
<source/>Stem Cell Rep.
          <year>2017</year>
<volume>9</volume>
<fpage>1885</fpage>
<lpage>1897</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2017.10.016</pub-id>
<pub-id pub-id-type="pmid">29153989</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-20-03862">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Domenico</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Calatayud</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pons-Espinal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Munoz</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Richaud-Patin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fernandez-Carasa</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gut</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Faella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Parameswaran</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patient-specific ipsc-derived astrocytes contribute to non-cell-autonomous neurodegeneration in parkinson’s disease</article-title>
<source/>Stem Cell Rep.
          <year>2019</year>
<volume>12</volume>
<fpage>213</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2018.12.011</pub-id>
<pub-id pub-id-type="pmid">30639209</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-20-03862">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juopperi</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>G.-L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells</article-title>
<source/>Mol. Brain
          <year>2012</year>
<volume>5</volume>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.1186/1756-6606-5-17</pub-id>
<pub-id pub-id-type="pmid">22613578</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-20-03862">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallmann</surname>
<given-names>A.-L.</given-names>
</name>
<name>
<surname>Araúzo-Bravo</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Mavrommatis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Röpke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brockhaus</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Missler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sterneckert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schöler</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Kuhlmann</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>42991</fpage>
<pub-id pub-id-type="doi">10.1038/srep42991</pub-id>
<pub-id pub-id-type="pmid">28256506</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-20-03862">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bilican</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Barmada</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Siller</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Burr</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Haghi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Story</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>A.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>4697</fpage>
<lpage>4702</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1300398110</pub-id>
<pub-id pub-id-type="pmid">23401527</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-20-03862">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Goparaju</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Tooi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nakatsuji</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Amyotrophic Lateral Sclerosis Model Derived from Human Embryonic Stem Cells Overexpressing Mutant Superoxide Dismutase 1</article-title>
<source/>Stem Cells Transl. Med.
          <year>2012</year>
<volume>1</volume>
<fpage>396</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.5966/sctm.2011-0061</pub-id>
<pub-id pub-id-type="pmid">23197818</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-20-03862">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyzack</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Sibley</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Cymes</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Forostyak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carlino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>I.F.</given-names>
</name>
<name>
<surname>Schiavo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Gibbons</surname>
<given-names>G.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models</article-title>
<source/>Nat. Commun.
          <year>2017</year>
<volume>8</volume>
<fpage>1164</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-01283-z</pub-id>
<pub-id pub-id-type="pmid">29079839</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-20-03862">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGivern</surname>
<given-names>J.V.</given-names>
</name>
<name>
<surname>Patitucci</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Nord</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Barabas</surname>
<given-names>M.-E.A.</given-names>
</name>
<name>
<surname>Stucky</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production</article-title>
<source/>Glia
          <year>2013</year>
<volume>61</volume>
<fpage>1418</fpage>
<lpage>1428</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22522</pub-id>
<pub-id pub-id-type="pmid">23839956</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-20-03862">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Funayama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsukita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Era</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Osaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ayaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes</article-title>
<source/>Acta Neuropathol. Commun.
          <year>2016</year>
<volume>4</volume>
<fpage>607</fpage>
<pub-id pub-id-type="doi">10.1186/s40478-016-0337-0</pub-id>
<pub-id pub-id-type="pmid">27402089</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-20-03862">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Warden</surname>
<given-names>C.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease</article-title>
<source/>Cell Stem Cell
          <year>2018</year>
<volume>23</volume>
<fpage>239</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2018.07.009</pub-id>
<pub-id pub-id-type="pmid">30075130</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-20-03862">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perriot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mathias</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perriard</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Canales</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jonkmans</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Merienne</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Meunier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>El Kassar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Perrier</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Laplaud</surname>
<given-names>D.-A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines</article-title>
<source/>Stem Cell Rep.
          <year>2018</year>
<volume>11</volume>
<fpage>1199</fpage>
<lpage>1210</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2018.09.015</pub-id>
<pub-id pub-id-type="pmid">30409508</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-20-03862">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russo</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Freitas</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Pignatari</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>I.R.</given-names>
</name>
<name>
<surname>Sebat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Muotri</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Beltrão-Braga</surname>
<given-names>P.C.B.</given-names>
</name>
</person-group>
<article-title>Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells</article-title>
<source/>Boil. Psychiatry
          <year>2018</year>
<volume>83</volume>
<fpage>569</fpage>
<lpage>578</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.09.021</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-20-03862">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ananiev</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>J.C.C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons</article-title>
<source/>Hum. Mol. Genet.
          <year>2014</year>
<volume>23</volume>
<fpage>2968</fpage>
<lpage>2980</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu008</pub-id>
<pub-id pub-id-type="pmid">24419315</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-20-03862">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andoh-Noda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akamatsu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sanosaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ohyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage</article-title>
<source/>Mol. Brain
          <year>2015</year>
<volume>8</volume>
<fpage>136</fpage>
<pub-id pub-id-type="doi">10.1186/s13041-015-0121-2</pub-id>
<pub-id pub-id-type="pmid">26012557</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-20-03862">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delepine</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Meziane</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nectoux</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Opitz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Ballatore</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Saillour</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bennaceur-Griscelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>E.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered microtubule dynamics and vesicular transport in mouse and human mecp2-deficient astrocytes</article-title>
<source/>Hum. Mol. Genet.
          <year>2016</year>
<volume>25</volume>
<fpage>146</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddv464</pub-id>
<pub-id pub-id-type="pmid">26604147</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-20-03862">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishii</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shoji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Asami</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kawamata</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Human induced pluripotent stem cell (hipsc)-derived neurons respond to convulsant drugs when co-cultured with hipsc-derived astrocytes</article-title>
<source/>Toxicology
          <year>2017</year>
<volume>389</volume>
<fpage>130</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2017.06.010</pub-id>
<pub-id pub-id-type="pmid">28666936</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-20-03862">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Wernig</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>I.D.</given-names>
</name>
<name>
<surname>Brüstle</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>In vitro differentiation of transplantable neural precursors from human embryonic stem cells</article-title>
<source/>Nat. Biotechnol.
          <year>2001</year>
<volume>19</volume>
<fpage>1129</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1201-1129</pub-id>
<pub-id pub-id-type="pmid">11731781</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-20-03862">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reubinoff</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Itsykson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Turetsky</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pera</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Reinhartz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Itzik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ben-Hur</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Neural progenitors from human embryonic stem cells</article-title>
<source/>Nat. Biotechnol.
          <year>2001</year>
<volume>19</volume>
<fpage>1134</fpage>
<lpage>1140</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1201-1134</pub-id>
<pub-id pub-id-type="pmid">11731782</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-20-03862">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krencik</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.-C.</given-names>
</name>
</person-group>
<article-title>Directed Differentiation of Functional Astroglial Subtypes from Human Pluripotent Stem Cells</article-title>
<source/>Nat. Protoc.
          <year>2011</year>
<volume>6</volume>
<fpage>1710</fpage>
<lpage>1717</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2011.405</pub-id>
<pub-id pub-id-type="pmid">22011653</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-20-03862">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caiazzo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giannelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lignani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Carissimo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sessa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Colasante</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bartolomeo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Massimino</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ferroni</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct conversion of fibroblasts into functional astrocytes by defined transcription factors</article-title>
<source/>Stem Cell Rep.
          <year>2015</year>
<volume>4</volume>
<fpage>25</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.12.002</pub-id>
<pub-id pub-id-type="pmid">25556566</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-20-03862">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaltouki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Efficient Generation of Astrocytes from Human Pluripotent Stem Cells in Defined Conditions</article-title>
<source/>Stem Cells
          <year>2013</year>
<volume>31</volume>
<fpage>941</fpage>
<lpage>952</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1334</pub-id>
<pub-id pub-id-type="pmid">23341249</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-20-03862">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Harder</surname>
<given-names>C.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fast Generation of Functional Subtype Astrocytes from Human Pluripotent Stem Cells</article-title>
<source/>Stem Cell Rep.
          <year>2018</year>
<volume>11</volume>
<fpage>998</fpage>
<lpage>1008</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2018.08.019</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-20-03862">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kamiya</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Katayama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nozaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mizuseki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sasai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Directed differentiation of telencephalic precursors from embryonic stem cells</article-title>
<source/>Nat. Neurosci.
          <year>2005</year>
<volume>8</volume>
<fpage>288</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1038/nn1402</pub-id>
<pub-id pub-id-type="pmid">15696161</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-20-03862">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eiraku</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsuo-Takasaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yonemura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Matsumura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wataya</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Muguruma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sasai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Self-Organized Formation of Polarized Cortical Tissues from ESCs and Its Active Manipulation by Extrinsic Signals</article-title>
<source/>Cell Stem Cell
          <year>2008</year>
<volume>3</volume>
<fpage>519</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2008.09.002</pub-id>
<pub-id pub-id-type="pmid">18983967</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-20-03862">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Delsing</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Clausen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ricchiuto</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sabirsh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Synnergren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zetterberg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brolén</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models</article-title>
<source/>Stem Cell Rep.
          <year>2018</year>
<volume>10</volume>
<fpage>1030</fpage>
<lpage>1045</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2018.01.021</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-20-03862">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Funayama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsukita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hotta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Okano</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice</article-title>
<source/>Stem Cell Rep.
          <year>2014</year>
<volume>3</volume>
<fpage>242</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.05.017</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-20-03862">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyzack</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lakatos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Patani</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Human Stem Cell-Derived Astrocytes: Specification and Relevance for Neurological Disorders</article-title>
<source/>Curr. Stem Cell Rep.
          <year>2016</year>
<volume>2</volume>
<fpage>236</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1007/s40778-016-0049-1</pub-id>
<pub-id pub-id-type="pmid">27547709</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-20-03862">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Fasano</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Papapetrou</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Tomishima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sadelain</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling</article-title>
<source/>Nat. Biotechnol.
          <year>2009</year>
<volume>27</volume>
<fpage>275</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.1529</pub-id>
<pub-id pub-id-type="pmid">19252484</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-20-03862">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kesavan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Takashima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ladewig</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wiskow</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Tailor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Trotter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pollard</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e29597</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0029597</pub-id>
<pub-id pub-id-type="pmid">22272239</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-20-03862">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lippmann</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Ruhl</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Estevez-Silva</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Ashton</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Deterministic HOX Patterning in Human Pluripotent Stem Cell-Derived Neuroectoderm</article-title>
<source/>Stem Cell Rep.
          <year>2015</year>
<volume>4</volume>
<fpage>632</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2015.02.018</pub-id>
<pub-id pub-id-type="pmid">25843047</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-20-03862">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osakada</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Neural induction and patterning in Mammalian pluripotent stem cells</article-title>
<source/>CNS Neurol. Disord.-Drug Targets
          <year>2011</year>
<volume>10</volume>
<fpage>419</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.2174/187152711795563958</pub-id>
<pub-id pub-id-type="pmid">21495966</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-20-03862">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.-C.</given-names>
</name>
</person-group>
<article-title>Neural Subtype Specification from Human Pluripotent Stem Cells</article-title>
<source/>Cell Stem Cell
          <year>2016</year>
<volume>19</volume>
<fpage>573</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2016.10.015</pub-id>
<pub-id pub-id-type="pmid">27814479</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-20-03862">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krencik</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Weick</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.-J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.-C.</given-names>
</name>
</person-group>
<article-title>Specification of Transplantable Astroglial Subtypes from Human Pluripotent Stem Cells</article-title>
<source/>Nat. Biotechnol.
          <year>2011</year>
<volume>29</volume>
<fpage>528</fpage>
<lpage>534</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.1877</pub-id>
<pub-id pub-id-type="pmid">21602806</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-20-03862">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roybon</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lamas</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Garcia-Diaz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Sattler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jackson-Lewis</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.A.</given-names>
</name>
<name>
<surname>Kachel</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Przedborski</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human Stem Cell-Derived Spinal Cord Astrocytes with Defined Mature or Reactive Phenotypes</article-title>
<source/>Cell Rep.
          <year>2013</year>
<volume>4</volume>
<fpage>1035</fpage>
<lpage>1048</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.021</pub-id>
<pub-id pub-id-type="pmid">23994478</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-20-03862">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmqvist</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brouwer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Djelloul</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Devine</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Hammarberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fog</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kunath</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Roybon</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors</article-title>
<source/>Stem Cell Res.
          <year>2015</year>
<volume>15</volume>
<fpage>203</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1016/j.scr.2015.05.014</pub-id>
<pub-id pub-id-type="pmid">26100233</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-20-03862">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Purification and Characterization of Astrocyte Precursor Cells in the Developing Rat Optic Nerve</article-title>
<source/>J. Neurosci.
          <year>1999</year>
<volume>19</volume>
<fpage>1049</fpage>
<lpage>1061</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-03-01049.1999</pub-id>
<pub-id pub-id-type="pmid">9920668</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-20-03862">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>De Vellis</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Growth of purified astrocytes in a chemically defined medium</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1981</year>
<volume>78</volume>
<fpage>7205</fpage>
<lpage>7209</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.78.11.7205</pub-id>
<pub-id pub-id-type="pmid">6458820</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-20-03862">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sloan</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Darmanis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Birey</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Caneda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reimer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Quake</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Paşca</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells</article-title>
<source/>Neuron
          <year>2017</year>
<volume>95</volume>
<fpage>779</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2017.07.035</pub-id>
<pub-id pub-id-type="pmid">28817799</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-20-03862">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiyoshi</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Terman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Syncytial isopotentiality: A system-wide electrical feature of astrocytic networks in the brain</article-title>
<source/>Glia
          <year>2018</year>
<volume>66</volume>
<fpage>2756</fpage>
<lpage>2769</lpage>
<pub-id pub-id-type="doi">10.1002/glia.23525</pub-id>
<pub-id pub-id-type="pmid">30277621</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-20-03862">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khakh</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Deneen</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The Emerging Nature of Astrocyte Diversity</article-title>
<source/>Annu. Rev. Neurosci.
          <year>2019</year>
<volume>42</volume>
<fpage>187</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-neuro-070918-050443</pub-id>
<pub-id pub-id-type="pmid">31283899</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-20-03862">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tchieu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Calder</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Guttikonda</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Gutzwiller</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Aromolaran</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Steinbeck</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells</article-title>
<source/>Nat. Biotechnol.
          <year>2019</year>
<volume>37</volume>
<fpage>267</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1038/s41587-019-0035-0</pub-id>
<pub-id pub-id-type="pmid">30804533</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-20-03862">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kubota</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Himuro</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chikenji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Otani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mizue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nagaishi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujimiya</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain</article-title>
<source/>Sci. Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>1712</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-19442-7</pub-id>
<pub-id pub-id-type="pmid">29374250</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-20-03862">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertram</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tanzi</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>Genome-wide association studies in alzheimer’s disease</article-title>
<source/>Hum. Mol. Genet.
          <year>2009</year>
<volume>18</volume>
<fpage>R137</fpage>
<lpage>R145</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddp406</pub-id>
<pub-id pub-id-type="pmid">19808789</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-20-03862">
<label>68.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.-J.</given-names>
</name>
<name>
<surname>Desplats</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Masliah</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Cell-to-Cell Transmission of α-Synuclein Aggregates</article-title>
<source/>Amyloid Proteins: Methods and Protocols
          <person-group person-group-type="editor">
<name>
<surname>Sigurdsson</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Calero</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gasset</surname>
<given-names>M.</given-names>
</name>
</person-group>
<publisher-name>Humana Press</publisher-name>
<publisher-loc>Totowa, NJ, USA</publisher-loc>
<year>2012</year>
<fpage>347</fpage>
<lpage>359</lpage>
</element-citation>
</ref>
<ref id="B69-ijms-20-03862">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>Genetics in parkinson disease: Mendelian versus non-mendelian inheritance</article-title>
<source/>J. Neurochem.
          <year>2016</year>
<volume>139</volume>
<issue>Suppl. 1</issue>
<fpage>59</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.13593</pub-id>
<pub-id pub-id-type="pmid">27090875</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-20-03862">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Z.-H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.-X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.-E.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.-J.</given-names>
</name>
</person-group>
<article-title>Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity</article-title>
<source/>J. Cell Boil.
          <year>2005</year>
<volume>171</volume>
<fpage>1001</fpage>
<lpage>1012</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200508072</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-20-03862">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Clinical aspects and pathology of alexander disease, and morphological and functional alteration of astrocytes induced by gfap mutation</article-title>
<source/>Neuropathol. Off. J. Jpn. Soc. Neuropathol.
          <year>2012</year>
<volume>32</volume>
<fpage>440</fpage>
<lpage>446</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1789.2011.01268.x</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-20-03862">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messing</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feany</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Alexander disease</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>5017</fpage>
<lpage>5023</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5384-11.2012</pub-id>
<pub-id pub-id-type="pmid">22496548</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-20-03862">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomokane</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Iwaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tateishi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Iwaki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold</article-title>
<source/>Am. J. Pathol.
          <year>1991</year>
<volume>138</volume>
<fpage>875</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="pmid">1707236</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-20-03862">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brosnan</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>The astrocyte in multiple sclerosis revisited</article-title>
<source/>Glia
          <year>2013</year>
<volume>61</volume>
<fpage>453</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22443</pub-id>
<pub-id pub-id-type="pmid">23322421</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-20-03862">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perriard</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mathias</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Enz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Canales</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schluep</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gentner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schaeren-Wiemers</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Du Pasquier</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes</article-title>
<source/>J. Neuroinflamm.
          <year>2015</year>
<volume>12</volume>
<fpage>119</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-015-0335-3</pub-id>
<pub-id pub-id-type="pmid">26077779</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-20-03862">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sztainberg</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Lessons learned from studying syndromic autism spectrum disorders</article-title>
<source/>Nat. Neurosci.
          <year>2016</year>
<volume>19</volume>
<fpage>1408</fpage>
<lpage>1417</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4420</pub-id>
<pub-id pub-id-type="pmid">27786181</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-20-03862">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maezawa</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Swanberg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>LaSalle</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>L.-W.</given-names>
</name>
</person-group>
<article-title>Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions</article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<fpage>5051</fpage>
<lpage>5061</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0324-09.2009</pub-id>
<pub-id pub-id-type="pmid">19386901</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-20-03862">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ananiev</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Isogenic Pairs of Wild Type and Mutant Induced Pluripotent Stem Cell (iPSC) Lines from Rett Syndrome Patients as In Vitro Disease Model</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e25255</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025255</pub-id>
<pub-id pub-id-type="pmid">21966470</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-20-03862">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyake</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Minakuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohori</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Soutome</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hirasawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kazuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparison of genomic and epigenomic expression in monozygotic twins discordant for rett syndrome</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e66729</elocation-id>
<pub-id pub-id-type="pmid">23805272</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-20-03862">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Progress in the molecular mechanisms of genetic epilepsies using patient-induced pluripotent stem cells</article-title>
<source/>Epilepsia Open
          <year>2018</year>
<volume>3</volume>
<fpage>331</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1002/epi4.12238</pub-id>
<pub-id pub-id-type="pmid">30187003</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-20-03862">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perea</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Navarrete</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Araque</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Tripartite synapses: Astrocytes process and control synaptic information</article-title>
<source/>Trends Neurosci.
          <year>2009</year>
<volume>32</volume>
<fpage>421</fpage>
<lpage>431</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2009.05.001</pub-id>
<pub-id pub-id-type="pmid">19615761</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-20-03862">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Azmi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Oberheim</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zielke</surname>
<given-names>H.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An astrocytic basis of epilepsy</article-title>
<source/>Nat. Med.
          <year>2005</year>
<volume>11</volume>
<fpage>973</fpage>
<lpage>981</lpage>
<pub-id pub-id-type="doi">10.1038/nm1277</pub-id>
<pub-id pub-id-type="pmid">16116433</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<table-wrap id="ijms-20-03862-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-20-03862-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Modeling astrocyte contributions in neurological disorders with human pluripotent stem cells.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Disease</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Source </th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene Mutation/Modification</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Alzheimer’s disease (AD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">APP E693Δ mutation<break></break>APP V717L mutation<break></break>Sporadic AD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kondo et al., 2013 [<xref ref-type="bibr" rid="B24-ijms-20-03862">24</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Alzheimer’s disease (AD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PSEN1 exon 9 deletion</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Oksanen et al., 2017 [<xref ref-type="bibr" rid="B25-ijms-20-03862">25</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parkinson’s disease (PD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LRRK2 G2019S mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">di Domenico et al., 2019 [<xref ref-type="bibr" rid="B26-ijms-20-03862">26</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Huntington’s disease (HD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HTT CAG repeat expansion</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Juopperi et al. 2012 [<xref ref-type="bibr" rid="B27-ijms-20-03862">27</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tauopathy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MAPT N279K mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hallmann et al. 2017 [<xref ref-type="bibr" rid="B28-ijms-20-03862">28</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TDP-43 proteinopathy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TDP-43 M337V mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Serio et al., 2013 [<xref ref-type="bibr" rid="B29-ijms-20-03862">29</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Amyotrophic lateral sclerosis (ALS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Human ESCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SOD1 G93A overexpressing</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Wada et al., 2012 [<xref ref-type="bibr" rid="B30-ijms-20-03862">30</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Amyotrophic lateral sclerosis (ALS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SOD1 D90A mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tyzack et al., 2017 [<xref ref-type="bibr" rid="B31-ijms-20-03862">31</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Spinal muscular atrophy (SMA)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SMN1 exons 7 and 8 deletion</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">McGivern et al., 2013 [<xref ref-type="bibr" rid="B32-ijms-20-03862">32</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Alexander’s disease (AxD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GFAP R239C mutation<break></break>GFAP E69K mutation<break></break>GFAP L264P mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kondo et al., 2016 [<xref ref-type="bibr" rid="B33-ijms-20-03862">33</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Alexander’s disease (AxD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GFAP R239C mutation<break></break>GFAP R79C mutation<break></break>GFAP M73K mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Li et al., 2018 [<xref ref-type="bibr" rid="B34-ijms-20-03862">34</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Multiple sclerosis (MS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Perriot et al., 2018 [<xref ref-type="bibr" rid="B35-ijms-20-03862">35</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Autism spectrum disorder (ASD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Russo et al., 2018 [<xref ref-type="bibr" rid="B36-ijms-20-03862">36</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Rett syndrome (RTT)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MECP2 V247X mutation<break></break>MECP2 R294X mutation<break></break>MECP2 R306C mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Williams et al., 2014 [<xref ref-type="bibr" rid="B37-ijms-20-03862">37</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Rett syndrome (RTT)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MECP2 G269AfsX288 mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Andoh-Noda et al., 2015 [<xref ref-type="bibr" rid="B38-ijms-20-03862">38</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Rett syndrome (RTT)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Patient derived iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MECP2 R294X mutation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Delépine et al., 2016 [<xref ref-type="bibr" rid="B39-ijms-20-03862">39</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Drug-induced epilepsy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Human iPSCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ishii et al., 2017 [<xref ref-type="bibr" rid="B40-ijms-20-03862">40</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>